Determination of Optimal Dose of Aspirin in Secondary Prevention of Cerebrovascular Diseases by Optical Aggregometry and comparing the results with manual method.
Not Applicable
- Registration Number
- CTRI/2010/091/001224
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 116
Inclusion Criteria
Subjects for platelet aggregation test should be resting, fasting and non-smoking. Stroke patient with ASA/Anticoagulant drugs or both. Healthy Controls for Comparison.
Exclusion Criteria
Patients : with Bleed, Haemorrhage will be excluded.
For controls: no medication, no risk factors like HT,DM,IHD etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method